Oncolytics Biotech® prices public offering of units
Oncolytics Biotech® announced the pricing of an underwritten public offering of 14,300,000 units at a purchase price of $0.70 per Unit for gross proceeds of $10,010,000. Each Unit will be comprised of one common share of the Company and one common share purchase warrant. May 24, 2017